Free Trial

Genus (LON:GNS) Shares Pass Above 200 Day Moving Average - What's Next?

Genus logo with Medical background

Genus plc (LON:GNS - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,819.47 ($23.62) and traded as high as GBX 2,070 ($26.88). Genus shares last traded at GBX 2,065 ($26.81), with a volume of 39,814 shares trading hands.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft cut their target price on Genus from GBX 2,300 ($29.86) to GBX 2,150 ($27.91) and set a "buy" rating on the stock in a research report on Wednesday, July 17th.

View Our Latest Research Report on GNS

Genus Trading Up 2.2 %

The company's 50 day moving average price is GBX 1,913.10 and its two-hundred day moving average price is GBX 1,819.47. The firm has a market cap of £1.35 billion, a PE ratio of 17,208.33, a P/E/G ratio of 2.87 and a beta of 0.37. The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.54.

Genus Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, December 6th. Shareholders of record on Thursday, November 7th will be paid a GBX 21.70 ($0.28) dividend. The ex-dividend date is Thursday, November 7th. This represents a yield of 1.21%. This is an increase from Genus's previous dividend of $10.30. Genus's dividend payout ratio (DPR) is presently 26,666.67%.

Insider Buying and Selling at Genus

In other Genus news, insider Iain Ferguson purchased 3,000 shares of Genus stock in a transaction dated Thursday, September 5th. The shares were purchased at an average cost of GBX 1,800 ($23.37) per share, for a total transaction of £54,000 ($70,111.66). In related news, insider Jorgen Kokke sold 2,186 shares of the firm's stock in a transaction dated Monday, September 16th. The shares were sold at an average price of GBX 1,956 ($25.40), for a total value of £42,758.16 ($55,515.66). Also, insider Iain Ferguson acquired 3,000 shares of the stock in a transaction on Thursday, September 5th. The stock was bought at an average cost of GBX 1,800 ($23.37) per share, with a total value of £54,000 ($70,111.66). Company insiders own 0.75% of the company's stock.

Genus Company Profile

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Stories

Should you invest $1,000 in Genus right now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines